Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial

Circulation

Volumn 98, Issue 8, 1998, Pages 757-765

  Spaulding, Christian ^a   Charbonnier, Bernard ^a   Cohen Solal, Alain ^a   Juillière, Yves ^a   Kromer, Eckhard Peter ^a   Benhamda, Khaldoun ^a   Cador, Romain ^a   Weber, Simon ^a  

^a René Descartes University ^*  (France)

Author keywords

Angiotensin; Aspirin; Coronary disease; Heart failure; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PROSTAGLANDIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; LUNG RESISTANCE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0032566393     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.8.757     Document Type: Article

References (36)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
2. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
3. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997;133:703-712.
4. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22(A):6A-13A.
5. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med. 1988;318:262-264.
6. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE III, Schnaper HW, LeWinter MN, Linares E, Pouget JM, Sabharwal SC, Chesler E, De Mots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med. 1983;309:396-403.
7. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilatory effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 1992; 20:1549-1555.
8. Swedberg K, Held P, Kjekshus J, Ramussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study Group II (CONSENSUS II). N Engl J Med. 1992;327:678-684.
9. Nguyen KN, Aursnes I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Am J Cardiol. 1997;79:115-119.
10. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971;231:232-235.
11. Schömig A, Neumann F-J, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Roth E-M, Richart G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334: 1084-1089.
12. Cospite M, Ferrara F, Milio G, Scrivano V, Meli F. Ticlopidine in the treatment of multiple atherosclerotic arteriopathy: a stain gauge plethysmography and Doppler spectrum analysis evaluation. J Int Med Res. 1987;15:303-311.
13. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AG. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1: 1215-1220.
14. Panak E, Maffrand JP, Picard-Fraire C, Vallée E, Blanchard J, Roncucci R. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications. Haemostasis. 1983;13(suppl 1):1-54.
15. Evans MA, Burnett JC, Redfield MM. Effect of a low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure. J Am Coll Cardiol. 1995;25: 1445-1450.
16. Nishimura H, Kubo S, Ueyama M, Kubota J, Kawamura K. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J. 1989;117:100-105.
17. Townend JN, Doran J, Lote CJ, Davies MK. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Br Heart J. 1995;73:434-441.
18. van Wijngaarden, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SAJ, van Veldhuisen DJ, Lie KI, Wesseling H. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 1994;23:240-245.
19. Baur LHB, Schipperheyn JJ, van der Laarse A, Souverijn JHM, Frölich M, de Groot A, Voogd PJ, Vroom TFFP, Manger Cats V, Keirse MJNC, Bruschke AVG. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J. 1995;73:227-236.
20. Smith SR, Coffman TM, Svetkey LP. Effect of low-dose aspirin on thromboxane production and the hypertensive effect of captopril. J Am Soc Nephrol. 1993;4:1133-1139.
21. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
22. Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA Jr. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med. 1983;308:800-805.
23. DiCarlo L, Chatterjee K, Parmley WW, Swedberg K, Atherton B, Curran D, Cucci M. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol. 1983;2:865-871.
24. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation. 1990; 82:1724-1729.
25. Packer M. Pathophysiology of chronic heart failure. Lancet. 1992;340: 88-92.
26. Lyons D, Roy S, O'Byrne S, Swift CG. ACE inhibition: postsynaptic adrenergic sympatholytic action in men. Circulation. 1997;96:911-915.
27. Noll G, Wenzel RR, de Marchi S, Shaw S, Luscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation. 1997;95:2286-2292.
28. Dzau VJ, Swartz SL. Dissociation of prostaglandin and renin angiotensin 7 systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1987;60:1101-1105.
29. Gambone LM, Murray PA, Flavahan NA. Synergistic interaction between endothelium-derived NO and prostacyclin in pulmonary artery: potential role for K+ATP channels. Br J Pharmacol. 1997;121:271-279.
30. Baggia S, Perkins K, Greenberg B. Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure. J Cardiovasc Pharmacol. 1997;29:389-396.
31. Lechat P, Ghouadni A, Barthelemy L, Mougenot N, Maistre M, Carayon A. Differential effects of angiotensin-converting enzyme inhibition by quinapril on tissular levels of bradykinin in rats. Eur Heart J. 1997; 18:265. Abstract.
32. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501-507.
33. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb. 1993;13:1171-1179.
34. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
35. SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
36. Sze PC, Reitman D, Pincus MM, Sacks HS, Chalmers TC. Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials. Stroke. 1988;19:436-452.